|

Infectious Complications After Cystectomy: A Prospective Observational Study

RECRUITINGSponsored by Ludwig-Maximilians - University of Munich
Actively Recruiting
SponsorLudwig-Maximilians - University of Munich
Started2021-12-01
Est. completion2024-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05153694

Summary

Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical history, detailed prospective documentation of clinicopathological parameters, and serial measurements of infectious markers pre- and post-operatively. In-hospital complications are meticulously recorded, and long-term outcomes assessed through structured follow-up interviews at 3, 6, and 12 months. These follow-ups utilize standardized questionnaires to evaluate post-discharge infectious complications and gather patients' perspectives on their in-hospital experiences, providing a robust understanding of both clinical outcomes and patient-reported experiences.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Disease which requires removal of the urinary bladder

Exclusion Criteria:

* Patient does not want to participate

Conditions9

Bladder CancerCancerInfection WoundInfection, BacterialInfection, HospitalInfectionsUrinary Bladder DiseasesUrinary Tract DiseaseUrinary Tract Infections

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.